Effect of β-Blockers on Endothelial Function During Biological Aging: A Nanotechnological Approach

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2008-02-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1097/FJC.0b013e31816017f8PMID 18287890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MECHANISMS UNDERLYING NEBIVOLOL‐INDUCED ENDOTHELIAL NITRIC OXIDE SYNTHASE ACTIVATION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS

  2006cited by this paper
• Differential Activation of Mitogenic Signaling Pathways in Aortic Smooth Muscle Cells Deficient in Superoxide Dismutase Isoforms

  2005cited by this paper
• Endothelial aging.

  2005cited by this paper
• Oxidative Stress and Vascular Disease

  2004cited by this paper
• Impaired l-Arginine Transport and Endothelial Function in Hypertensive and Genetically Predisposed Normotensive Subjects

  2004cited by this paper
• Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor

  2003cited by this paper
• Third-Generation &bgr;-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action

  2003cited by this paper
• Extended-Release Metoprolol Succinate in Chronic Heart Failure

  2003cited by this paper
• Endothelial Dysfunction: A Marker of Atherosclerotic Risk

  2003cited by this paper
• Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release

  2002cited by this paper
• Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study

  2002cited by this paper
• Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia

  2002cited by this paper
• Role of Endothelial Nitric Oxide in Shear Stress—Induced Vasodilation of Human Microvasculature: Diminished Activity in Hypertensive and Hypercholesterolemic Patients

  2001cited by this paper
• beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.

  2000cited by this paper
• Enhanced Peroxynitrite Formation Is Associated with Vascular Aging

  2000cited by this paper
• In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure

  2000cited by this paper
• Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability.

  2000cited by this paper
• Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

  2000cited by this paper
• Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.

  2000cited by this paper
• Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

  2000cited by this paper
• Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.

  1999cited by this paper
• Endothelial dysfunction in human disease.

  1999cited by this paper
• Endothelium and acute coronary syndromes.

  1998cited by this paper
• Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.

  1998cited by this paper
• Preparation and optimization of superoxide microbiosensor

  1998cited by this paper
• Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis.

  1998cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Cellular and molecular mechanisms of endothelial cell dysfunction.

  1997cited by this paper
• Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism.

  1997cited by this paper
• Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

  1996cited by this paper
• Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery.

  1996cited by this paper
• IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

  1996cited by this paper
• Comparative antioxidant effects of beta-adrenoceptor blockers, calcium antagonists and U-74500A against iron-dependent lipid peroxidation in murine ventricular microsomal membranes.

  1996cited by this paper
• The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.

  1995cited by this paper
• Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

  1993cited by this paper
• Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

  1992cited by this paper
• Endothelial function in chronic congestive heart failure.

  1992cited by this paper
• Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor

  1992cited by this paper
• Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.

  1990cited by this paper
• Propranolol as xanthine oxidase inhibitor: implications for antioxidant activity.

  1989cited by this paper
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

  1987cited by this paper
• Alterations of Vascular Reactivity in Atherosclerosis

  1987cited by this paper
• Some Statistical Methods Useful in Circulation Research

  1980cited by this paper

• Effects of plant- and animal-based-protein meals for a day on serum nitric oxide and peroxynitrite levels in healthy young men.

  2024cites this paper
• Hypertension and cellular senescence

  2023cites this paper
• A Unified Model of Age-Related Cardiovascular Disease

  2022cites this paper
• Protective role of vitamin D against oxidative stress in diabetic retinopathy

  2021cites this paper
• An Overview of NO Signaling Pathways in Aging

  2021cites this paper
• Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D3 – clinical implications for cardiovascular diseases

  2018cites this paper
• Estudo da associação do treinamento físico aeróbio com diferentes terapias farmacológicas sobre as adaptações autonômicas cardíacas em ratos espontaneamente hipertensos (SHR)

  2016cites this paper
• Nitric Oxide/Peroxynitrite Imbalance Induces Adhesion of Cancer Cells to Lymphatic Endothelium - Clinical Implications for Cancer Metastasis

  2015cites this paper
• Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.

  2015cites this paper
• Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes.

  2014cites this paper
• Oxidative Stress Damages the Endothelium

  2014cites this paper
• Development and Validation of a Clinical Risk Score Predicting the No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

  2013cites this paper
• Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques.

  2013cites this paper
• Combined use of calcium channel blockers and inhibitors of the renin-angiotensin system for treating hypertension

  2011cites this paper
• Metoprolol Ameliorates Cyclosporine A–induced Hypertension and Nephrotoxicity in Rats

  2011cites this paper
• Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).

  2011cites this paper
• What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?

  2009cites this paper
• Nitric Oxide/Peroxynitrite Balance in Kidney – Effect of Diabetes and Obesity

  2008cites this paper